UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 28, 2004

AMSURG CORP.

(Exact Name of Registrant as Specified in Charter)

Tennessee	000-22217	62-1493316
(State or Other Jurisdiction of	(Commission	(I.R.S. Employer
Incorporation)	File Number)	Identification No.)

20 Burton Hills Boulevard
Nashville, Tennessee	37215
(Address of Principal Executive Offices)	(Zip Code)

(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS

	Item 7.01. Regulation FD Disclosure
SIGNATURES

Item 7.01. Regulation FD Disclosure

     On October 26, 2004, the Company issued a press release announcing its earnings for the third quarter of 2004 and held a conference call to discuss the release. During the call, additional information about the first and second quarters of 2004 was requested in connection with the disposal of a surgery center on August 1, 2004, which was presented as part of discontinued operations in the Company’s results of operations for the three and nine months ended September 30, 2004. In response to such request, the Company is providing the following statement of earnings data, presenting the center’s results of operations as discontinued operations in the three months ended March 31, 2004 and June 30, 2004 and six months ended June 30, 2004. Procedures performed by centers in continuing operations were 146,669 and 154,531 in the three months ended March 31, 2004 and June 30, 2004, respectively.

Statements of Earnings Data (in thousands, except per share amounts):

	Three Months Ended
					Six Months Ended
	March 31, 2004		June 30, 2004		June 30, 2004
Revenues	$	79,746	$	84,339	$	164,085
Operating expenses:
Salaries and benefits		21,662		22,316		43,978
Supply cost		8,990		9,560		18,550
Other operating expenses		15,689		16,964		32,653
Loss on long-term note receivable		—		1,100		1,100
Depreciation and amortization		3,211		3,309		6,520
Total operating expenses		49,552		53,249		102,801
Operating income		30,194		31,090		61,284
Minority interest		16,651		17,568		34,219
Interest expense, net of interest income		427		505		932
Earnings from continuing operations before income taxes		13,116		13,017		26,133
Income tax expense		5,246		5,207		10,453
Net earnings from continuing operations		7,870		7,810		15,680
Discontinued operations:
Earnings from operations of discontinued interests in surgery centers, net of income taxes.		509		424		933
Gain on sale of discontinued interests in surgery centers, net of income taxes		1,241		—		1,241
Earnings from discontinued operations		1,750		424		2,174
Net earnings	$	9,620	$	8,234	$	17,854
Basic earnings per common share:
Net earnings from continuing operations	$	0.26	$	0.26	$	0.52
Net earnings	$	0.32	$	0.27	$	0.59
Diluted earnings per common share:
Net earnings from continuing operations	$	0.26	$	0.25	$	0.51
Net earnings	$	0.31	$	0.27	$	0.58
Weighted average number of shares and share equivalents outstanding:
Basic		30,158		30,238		30,198
Diluted		30,832		30,862		30,847

2

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AMSURG CORP.
	By:	/s/ Claire M. Gulmi
		Claire M. Gulmi
Date: October 28, 2004		Senior Vice President and Chief Financial Officer (Principal Financial and Duly Authorized Officer)

3